Abstract
Experimental autoimmune encephalomyelitis (EAE) is a mouse model that serves as an experimental tool for studying the etiology, pathogenesis, as well as new therapeutic approaches of multiple sclerosis (MS). EAE is a polygenic chronic inflammatory demyelinating disease of the nervous system that involves the interaction between genetic and environmental factors. Previous studies have identified multiple quantitative trait loci (QTL) controlling different aspects of disease pathogenesis. However, progress in identifying new susceptibility genes outside the MHC locus has been slow. With the advent of new global methods for genetic analysis such as large-scale sequencing, gene expression profiling combined with classic linkage analysis and congenic and physical mapping progress is considerably accelerating. Here we review our preliminary work on the use of gene expression mapping to identify new putative genetic pathways contributing to the pathogenesis of EAE.
Similar content being viewed by others
REFERENCES
Slavin, A., Ewing, C., Liu, J., Ichikawa, M., Slavin, J., and Bernard, C. C. 1998. Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein. Autoimmunity 28:109-120.
Conlon, P., Oksenberg, J. R., Zhan, J., and Steinman, L. 1999. The immunobiology of multiple sclerosis: an autoimmune disease of the central nervous system. Neurobiol. Dis. 6:149-166.
Gold, R., Hartung, H. P., and Toyka, K. V. 2000. Animal models for autoimmune demyelinating disorders of the nervous system. Mol. Med. Today 6:88-91.
Lucchinetti, C., Bruck, W., Parisi, J., Scheithauer, B., Rodriguez, M., and Lassmann, H. 2000. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47:707-717.
Mendel, I., Kerlero de Rosbo, N., and Ben-Nun, A. 1995. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 25:1951-1959.
Storch, M. K., Stefferl, A., Brehm, U., Weissert, R., Wallstrom, E., Kerschensteiner, M., Olsson, T., Linington, C., and Lassmann, H. 1998. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 8:681-694.
Dahlman, I., Wallstrom, E., Weissert, R., Storch, M., Kornek, B., Jacobson, L., Linington, C., Luthman, H., Lassmann, H., and Olsson, T. 1999. Linkage analysis of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the rat identifies a locus controlling demyelination on chromosome 18. Hum. Mol. Genet. 8:2183-2190.
Bernard, C. C., Johns, T. G., Slavin, A., Ichikawa, M., Ewing, C., Liu, J., and Bettadapura, J. 1997. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J. Mol. Med. 75:77-88.
Haase, C. G., Guggenmos, J., Brehm, U., Andersson, M., Olsson, T., Reindl, M., Schneidewind, J. M., Zettl, U. K., Heidenreich, F., Berger, T., Wekerle, H., Hohlfeld, R., and Linington, C. 2001. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls. J. Neuroimmunol. 114:220-225.
Mokhtarian, F., Zhang, Z., Shi, Y., Gonzales, E., and Sobel, R. A. 1999. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice. J. Neuroimmunol. 95:43-54.
McFarland, H. I., Lobito, A. A., Johnson, M. M., Nyswaner, J. T., Frank, J. A., Palardy, G. R., Tresser, N., Genain, C. P., Mueller, J. P., Matis, L. A., and Lenardo, M. J. 1999. Determinant spreading associated with demyelination in a nonhuman primate model of multiple sclerosis. J. Immunol. 162:2384-2390.
Johns, T. G. and Bernard, C. C. 1997. Binding of complement component Clq to myelin oligodendrocyte glycoprotein: a novel mechanism for regulating CNS inflammation. Mol. Immunol. 34:33-38.
Griffiths, M. M., Encinas, J. A., Remmers, E. F., Kuchroo, V. K., and Wilder, R. L. 1999. Mapping autoimmunity genes. Curr. Opin. Immunol. 11:689-700.
Encinas, J. A., Weiner, H. L., and Kuchroo, V. K. 1996. Inheritance of susceptibility to experimental autoimmune encephalomyelitis. J. Neurosci. Res. 45:655-669.
Duggan, D. J., Bittner, M., Chen, Y., Meltzer, P., and Trent, J. M. 1999. Expression profiling using cDNA microarrays. Nat. Genet. 21(1 Suppl):10-14.
Ibrahim, S. M., Mix, E., Bottcher, T., Koczan, D., Gold, R., Rolfs, A., and Thiesen, H. J. 2001. Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis. Brain 124:1927-1938.
Ibrahim, S. M., Koczan, D., and Thiesen, H. J. 2002. Gene-Expression Profile of Collagen-induced Arthritis. J. Autoimmun. 18:159-167.
Broman, K. W. 2001. Review of statistical methods for QTL mapping in experimental crosses. Lab Anim. (NY) 30:44-52.
Wandstrat, A. and Wakeland, E. 2001. The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat. Immunol. 2:802-809.
Mir, K. U. The hypothesis is there is no hypothesis. 2000. The Microarray Meeting, Scottsdale, Arizona, USA, 22-25 September 1999. Trends Genet. 16:63-64.
Steinman, L. 2001. Gene microarrays and experimental demyelinating disease: a tool to enhance serendipity. Brain 124:1897-1899.
Wu, T. D. 2001. Analysing gene expression data from DNA microarrays to identify candidate genes. J. Pathol. 195:53-65.
Teague, T. K., Hildeman, D., Kedl, R. M., Mitchell, T., Rees, W., Schaefer, B. C., Bender, J., Kappler, J., and Marrack, P. 1999. Activation changes the spectrum but not the diversity of genes expressed by T cells. Proc. Natl. Acad. Sci. USA 96: 12691-12696.
Wittwer, C. T., Ririe, K. M., Andrew, R. V., David, D. A., Gundry, R. A., and Balis, U. J. 1997. The LightCycler: a micro-volume multisample fluorimeter with rapid temperature control. Biotechniques 22:176-181.
Zettl, U. K., Gold, R., Toyka, K. V., and Hartung, H. P. 1996. In situ demonstration of T cell activation and elimination in the peripheral nervous system during experimental autoimmune neuritis in the Lewis rat. Acta Neuropathol. (Berl.) 91:360-367.
Todd, J. A., Aitman, T. J., Cornall, R. J., Ghosh, S., Hall, J. R., Hearne, C. M., Knight, A. M., Love, J. M., McAleer, M. A., Prins, J. B., et al. 1991. Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature 351:542-547.
Dietrich, W. F., Miller, J., Steen, R., Merchant, M. A., Damron-Boles, D., Husain, Z., Dredge, R., Daly, M. J., Ingalls, K. A., O'Connor, T. J., et al. 1996. A comprehensive genetic map of the mouse genome. Nature 380:149-152.
Koh, D. R., Fung-Leung, W. P., Ho, A., Gray, D., Acha-Orbea, H., and Mak, T. W. 1992. Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/-mice. Science 256:1210-1213.
Davoust, N., Nataf, S., Reiman, R., Holers, M. V., Campbell, I. L., and Barnum, S. R. 1999. Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis. J. Immunol. 163:6551-6556.
Elliott, J. I., Douek, D. C., and Altmann, D. M. 1996. Mice lacking alpha beta + T cells are resistant to the induction of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 70:139-144.
Lyons, J. A., San, M., Happ, M. P., and Cross, A. H. 1999. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur. J. Immunol. 29:3432-3439.
Olsson, T. 1995. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 144:245-268.
Croxford, J. L., O'Neill, J. K., and Baker, D. 1997. Polygenic control of experimental allergic encephalomyelitis in Biozzi ABH and BALB/c mice. J. Neuroimmunol. 74:205-211.
Tada, Y., Ho, A., Matsuyama, T., and Mak, T. W. 1997. Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1. J. Exp. Med. 185:231-238.
Chabas, D., Baranzini, S. E., Mitchell, D., Bernard, C. C., Rittling, S. R., Denhardt, D. T., Sobel, R. A., Lock, C., Karpuj, M., Pedotti, R., Heller, R., Oksenberg, J. R., and Steinman, L. 2001. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science. 294:1731-1735.
Whitney, L. W., Ludwin, S. K., McFarland, H. F., and Biddison, W. E. 2001. Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions. J. Neuroimmunol. 121:40-48.
Wandinger, K. P., Sturzebecher, C. S., Bielekova, B., Detore, G., Rosenwald, A., Staudt, L. M., McFarland, H. F., and Martin, R. 2001. Upregulation of T helper 1-associated marker genes. Ann. Neurol. 50:349-357.
Bielekova, B., Goodwin, B., Richert, N., Cortese, I., Kondo, T., Afshar, G., Gran, B., Eaton, J., Antel, J., Frank, J. A., McFarland, H. F., and Martin, R. 2000. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nat. Med. 6:1167-1175.
Kappos, L., Comi, G., Panitch, H., Oger, J., Antel, J., Conlon, P., and Steinman, L. 2000. Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group. Nat. Med. 6:1176-1182.
Butterfield, R. J., Sudweeks, J. D., Blankenhorn, E. P., Korngold, R., Marini, J. C., Todd, J. A., Roper, R. J., and Teuscher, C. 1998. New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. J. Immunol. 161:1860-1867.
Teuscher, C., Rhein, D. M., Livingstone, K. D., Paynter, R. A., Doerge, R. W., Nicholson, S. M., and Melvold, R. W. 1997. Evidence that Tmevd2 and eae3 may represent either a common locus or members of a gene complex controlling susceptibility to immunologically mediated demyelination in mice. J. Immunol. 159:4930-4934.
Encinas, J. A., Lees, M. B., Sobel, R. A., Symonowicz, C., Greer, J. M., Shovlin, C. L., Weiner, H. L., Seidman, C. E., Seidman, J. G., and Kuchroo, V. K. 1996. Genetic analysis of susceptibility to experimental autoimmune encephalomyelitis in a cross between SJL/J and B10.S mice. J. Immunol. 157:2186-2192.
Sudweeks, J. D., Todd, J. A., Blankenhorn, E. P., Wardell, B. B., Woodward, S. R., Meeker, N. D., Estes, S. S., and Teuscher, C. 1993. Locus controlling Bordetella pertussis-induced histamine sensitization (Bphs), an autoimmune disease-susceptibility gene, maps distal to T-cell receptor beta-chain gene on mouse chromosome 6. Proc. Natl. Acad. Sci. 90:3700-3704.
Kuchroo, V. K., Anderson, A. C., Waldner, H., Munder, M., Bettelli, E., and Nicholson, L. B. 2002. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 20:101-123.
Butterfield, R. J., Blankenhorn, E. P., Roper, R. J., Zachary, J. F., Doerge, R. W., Sudweeks, J., Rose, J., and Teuscher, C. 1999. Genetic analysis of disease subtypes and sexual dimorphisms in mouse experimental allergic encephalomyelitis (EAE): relapsing/remitting and monophasic remitting/nonrelapsing EAE are immunogenetically distinct. J. Immunol. 162:3096-3102.
Baker, D., Rosenwasser, O. A., O'Neill, J. K., and Turk, J. L. 1995. Genetic analysis of experimental allergic encephalomyelitis in mice. J. Immunol. 150:4046-4051.
Butterfield, R. J., Blankenhorn, E. P., Roper, R. J., Zachary, J. F., Doerge, R. W., and Teuscher, C. 2000. Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis. Am. J. Pathol. 157:637-645.
Teuscher, C., Butterfield, R. J., Ma, R. Z., Zachary, J. F., Doerge, R. W., and Blankenhorn, E. P. 1999. Sequence polymorphisms in the chemokines Scya1 (TCA-3), Scya2 (monocyte chemo-attractant protein (MCP)-1), and Scya12 (MCP-5) are candidates for eae7, a locus controlling susceptibility to monophasic remitting/nonrelapsing experimental allergic encephalomyelitis. J. Immunol. 163:2262-2266.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mix, E., Pahnke, J. & Ibrahim, S.M. Gene-Expression Profiling of Experimental Autoimmune Encephalomyelitis. Neurochem Res 27, 1157–1163 (2002). https://doi.org/10.1023/A:1020925425780
Issue Date:
DOI: https://doi.org/10.1023/A:1020925425780